-
Bortezomib (PS-341): Precision Proteasome Inhibition in C...
2025-10-22
Bortezomib (PS-341) stands out as a reversible proteasome inhibitor, uniquely enabling mechanistic studies on apoptosis, proteostasis, and cancer therapy. This guide delivers actionable workflows, advanced troubleshooting, and novel applications that leverage Bortezomib’s potency and selectivity for unraveling complex proteasome-regulated cellular processes.
-
Vardenafil HCl Trihydrate: Enabling Proteoform-Selective ...
2025-10-21
Explore how Vardenafil HCl Trihydrate, a potent PDE5 inhibitor, empowers advanced research into cGMP signaling and vascular smooth muscle relaxation by facilitating proteoform-selective assays in native disease contexts. This article uniquely investigates its application for dissecting phosphodiesterase signaling in live tissue models.